Supplementary Materials, Tables, and Figures from Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics

PDF file, 321K, Serum pretreatment for CE-MS analysis Detailed conditions of capillary electrophoresis and mass spectrometry for betaine and propionylcarnitine analysis Tables S1-S5 Figure S1. Metabolic profiling of liver tissues. Figure S2. Study of the metabolic profiles of liver tissues. Figure S3. External validation of betaine and propionylcarnitine in cirrhosis and HCC patients. Figure S4. Significant differences of citramalic acid in tumor tissue in HBsAg-positive patients from HBsAg-negative ones.